U.S. Medical Equipment Stock News

NYSE:BBWI
NYSE:BBWISpecialty Retail

Bath & Body Works (BBWI) Valuation Check As Earnings Beat Hopes Confront Demand And Sales Headwinds

Bath & Body Works (BBWI) has reaffirmed a quarterly dividend of US$0.20 per share, payable on June 19, 2026, with an ex dividend and record date of June 5, 2026, drawing fresh attention to the stock. See our latest analysis for Bath & Body Works. At a share price of US$17.76, Bath & Body Works has seen short term share price returns of 2.5% over one day and 3.9% over seven days, but its 1 year total shareholder return has fallen 39.2%. This suggests that recent dividend reassurance and...
NYSE:LHX
NYSE:LHXAerospace & Defense

How Investors Are Reacting To L3Harris (LHX) Special-Meeting Vote And Fiber-Optic Tether Expansion

In May 2026, L3Harris Technologies announced that a shareholder proposal to enhance investors’ ability to call special meetings was voted down at its annual meeting, while separately confirming plans to expand production of fiber-optic tether systems used to maintain communications for military drones and underwater platforms in contested electronic warfare settings. This combination of governance continuity and increased focus on secure communications technology underscores how L3Harris is...
NYSE:APG
NYSE:APGConstruction

Will APi Group’s (APG) Expanded US$1 Billion Revolver and New Notes Reshape Its Investment Narrative

APi Group Corporation recently closed two major financing transactions, issuing US$500 million of 5.75% senior notes due 2034 and amending its credit agreement to extend term loan and revolving credit maturities while increasing the revolver to US$1.00 billion. By locking in longer-dated debt and expanding its revolving credit capacity, APi Group has materially increased its financial flexibility to fund acquisitions and other corporate initiatives. We will now examine how APi Group’s...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Erasca (ERAS) Is Up 9.9% After Merck Tie-Up And IP Challenge To ERAS-0015 - Has The Bull Case Changed?

Erasca, Inc. recently reported a first-quarter 2026 net loss of US$183.44 million and entered a past clinical trial collaboration and supply agreement with Merck to test its pan-RAS molecular glue ERAS-0015 alongside KEYTRUDA in RAS-mutant solid tumors. Soon after, Revolution Medicines’ patent infringement and trade secret claims against ERAS-0015 and the launch of multiple law firm investigations raised fresh questions about the durability of Erasca’s intellectual property position and...
NYSE:ENS
NYSE:ENSElectrical

Will Record 2026 Sales, Softer EPS and Upbeat Outlook Shift EnerSys' (ENS) Realignment Narrative?

EnerSys recently reported full-year 2026 results showing record net sales of US$3.75 billion, modest revenue growth over the prior year, but lower net income of US$293.56 million and reduced earnings per share. Alongside these results, the company raised attention with stronger-than-expected guidance for early fiscal 2027, continued dividends, and new battery products targeting data centers and outdoor communications networks. We’ll now examine how record sales, upbeat guidance, and cost...
NasdaqGM:DJT
NasdaqGM:DJTInteractive Media and Services

Is Trump Media & Technology Group (DJT) Fairly Priced After Sharp One-Year Share Price Decline

If you are looking at Trump Media & Technology Group and wondering whether the current share price reflects the underlying value, the recent moves give you plenty to think about. The stock closed at US$7.95, with the share price down 8.3% over the past week, down 16.1% over the past month and down 42.3% year to date, contributing to a 69.1% decline over the last year and a 39.0% decline over three years. Recent headlines around Trump Media & Technology Group have kept the stock in the...
NYSE:TEN
NYSE:TENOil and Gas

Tsakos Energy Navigation (TNP) EPS Surge Reinforces Bullish Profitability Narratives

Tsakos Energy Navigation (NYSE:TNP) opened 2026 with Q1 revenue of US$252.9 million and basic EPS of US$2.72, against a backdrop of trailing 12 month revenue of US$854.6 million and EPS of US$6.14 that was paired with 39.1% year over year earnings growth. Over recent quarters the company has seen revenue move from US$188.3 million in Q4 2024 to US$197.1 million in Q1 2025 and then to US$222.1 million in Q4 2025 before reaching the latest US$252.9 million print. Quarterly EPS shifted from...
NasdaqGS:NTNX
NasdaqGS:NTNXSoftware

Nutanix AMD Share Deal Raises Questions On Valuation And Future Alignment

Nutanix (NasdaqGS:NTNX) has issued over 4.1 million shares to AMD under a stock purchase agreement. The transaction, recently completed, totals US$150 million in new Nutanix equity issued to AMD. This share issuance introduces a large technology peer as a direct shareholder in Nutanix. Nutanix focuses on cloud software and hyperconverged infrastructure, with the goal of simplifying how enterprises run applications and data across private and public clouds. In the context of ongoing cloud...
NYSE:OTIS
NYSE:OTISMachinery

Did Otis Link MOD’s Global Escalator Upgrade Push Just Shift Otis Worldwide’s (OTIS) Investment Narrative?

Otis Worldwide recently launched its Otis Link MOD suite of commercial escalator modernization solutions worldwide, offering modular packages that upgrade safety, reliability, and efficiency for aging escalators while minimizing disruption by retaining existing trusses and using factory-preassembled components. A key insight is that Otis is targeting a modernization window covering roughly one-fifth of the world’s more than 1 million escalators, pairing this demand with IoT-enabled...
NYSE:VEEV
NYSE:VEEVHealthcare Services

Assessing Veeva Systems (VEEV) Valuation After A Prolonged Share Price Decline

Recent performance snapshot Veeva Systems (VEEV) has been on many investors’ radar after a challenging run, with the stock down about 27% year to date and about 31% over the past year. Over the past month the share price fell about 2%, extending a past 3 months decline of roughly 11%, even as the company reports annual revenue of US$3.20b and net income of US$908.91m. See our latest analysis for Veeva Systems. The stock’s short-term share price momentum has faded, with the 90 day share price...
NYSE:ET
NYSE:ETOil and Gas

Dakota Access Approval Refocuses Energy Transfer Risk And Growth Outlook

U.S. Army Corps of Engineers grants final approval for the Dakota Access Pipeline to remain operational. Approval includes new environmental safeguards focused on leak detection and groundwater monitoring. Decision directly affects Energy Transfer (NYSE:ET), which operates the Dakota Access Pipeline. Energy Transfer (NYSE:ET) is a major U.S. midstream company focused on transporting and storing oil and natural gas through a large pipeline network. The Army Corps decision on the Dakota...
NasdaqGS:DHC
NasdaqGS:DHCHealth Care REITs

Stronger Senior Housing And Credit Upgrade Might Change The Case For Investing In DHC

Diversified Healthcare Trust recently reported that its first-quarter results marked a move from stabilization to growth, underpinned by stronger senior housing operations, improved liquidity, and a credit rating upgrade that collectively eased perceived risk. The company also disclosed that its CEO and CFO previously presented at Nareit’s REITweek 2026 Investor Conference, offering investors additional insight into this evolving growth story. We’ll now explore how the shift from...
NYSE:BAX
NYSE:BAXMedical Equipment

Baxter International (BAX) Is Up 10.9% After Q1 Revenue Beat Refocuses Margin Recovery Narrative

Baxter International recently reported a strong first quarter, with revenue rising 2.9% year on year and exceeding analysts’ forecasts, following earlier indications of undervaluation and planned insider share sales disclosed via a Form 144 filing. This combination of better-than-expected operational performance and prior signals of perceived intrinsic value has sharpened attention on how effectively Baxter is executing its ongoing transformation efforts. With revenue outperforming...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

Assessing ImmunityBio (IBRX) Valuation After FDA Acceptance Of Anktiva sBLA For Papillary NMIBC

ImmunityBio (IBRX) is back in focus after the U.S. Food and Drug Administration accepted a supplemental Biologics License Application for Anktiva plus BCG in BCG unresponsive papillary non muscle invasive bladder cancer. See our latest analysis for ImmunityBio. Despite the latest sBLA news and recent patents and supply deals around Anktiva and BCG, ImmunityBio’s share price has cooled, with a 7 day share price return down 9.41% and a 30 day share price return down 10.53%, although the year to...
NasdaqGS:CHRW
NasdaqGS:CHRWLogistics

Jefferies Upgrade Puts C.H. Robinson AI Plans And Valuation In Focus

Jefferies has upgraded C.H. Robinson Worldwide (NasdaqGS:CHRW), citing the company's AI driven transformation and productivity push. The report points to C.H. Robinson's plan to use AI and automation to reshape its operations and improve efficiency. Jefferies also highlights the potential for C.H. Robinson to play a larger role in industry consolidation following the recent Supreme Court ruling in Montgomery vs. Caribe Transport II. C.H. Robinson enters this phase of change with its stock...
NYSE:DELL
NYSE:DELLTech

Is It Too Late To Consider Dell Technologies (DELL) After Its 131% Year To Date Surge?

With Dell Technologies trading at US$295.19, you might be wondering whether the stock still offers value or if most of the easy gains are already behind it. The share price movement has been strong, with returns of 22.0% over the past week, 37.5% over the past month and 131.0% year to date, while the 1 year return sits at 167.3% and the 3 and 5 year returns are both very large. Recent headlines have focused on Dell Technologies in areas such as AI related demand, enterprise hardware spending...
NasdaqGS:PEP
NasdaqGS:PEPBeverage

Is PepsiCo (PEP) Offering Value After Mixed Returns And DCF Upside Signals

Investors may be considering whether PepsiCo stock is offering fair value at around US$150, or if the recent price still leaves some upside potential for patient investors. Over the past year, PepsiCo has returned 21.1%, with the stock up 1.0% over the last 7 days, down 2.1% over the last 30 days, and up 5.9% year to date. Taken together, this provides a mixed picture of recent sentiment. At the same time, investors have been watching ongoing product launches and brand activity across...
NYSE:DECK
NYSE:DECKLuxury

Is It Time To Reassess Deckers Outdoor (DECK) After The Recent 14% Weekly Jump?

If you are trying to figure out whether Deckers Outdoor stock is attractively priced or not, it helps to start with what the recent share moves and current valuation are telling you. The stock last closed at US$106.67, with a 7 day return of 14.0%, while the 30 day return is down 0.9%, the year to date return is down 0.1%, and the 1 year return sits at 5.6% alongside 3 year and 5 year returns of 37.6% and 90.8% respectively. Recent coverage has focused on how the stock price path and those...
NasdaqGS:DOX
NasdaqGS:DOXIT

A Look At Amdocs (DOX) Valuation After Mixed Earnings Guidance Shift And CFO Transition

Why Amdocs stock is in focus after earnings, guidance and leadership changes Amdocs (DOX) is drawing fresh attention after its second quarter results combined higher sales with lower net income and earnings per share, alongside updated 2026 guidance and a planned CFO handover to long time insider Tal Rozenfeld. See our latest analysis for Amdocs. The mixed second quarter, revised 2026 guidance and upcoming CFO change appear to be playing out in the share price, with Amdocs at $62.66 and a 7...
NYSE:KLAR
NYSE:KLARDiversified Financial

Klarna Group (NYSE:KLAR) Valuation Check As Shares Rebound After A Weak Start To The Year

Klarna Group stock: recent performance in focus Klarna Group (KLAR) has drawn attention after a recent stretch of mixed returns, with the stock up over the past week and month, yet down about 42% so far this year. See our latest analysis for Klarna Group. The recent 1 month share price return of 11.96% and 3 month share price return of 26.68% contrast with the share price being down 42% year to date, suggesting momentum has picked up after a weak start to the year. If Klarna’s rebound has...
NYSE:AMN
NYSE:AMNHealthcare

Eric Palmer Joins AMN Board As Investors Weigh M&A And Growth Priorities

AMN Healthcare Services (NYSE:AMN) has elected Eric Palmer to its Board of Directors. Palmer is a healthcare services and M&A leader with senior experience at Evernorth Health Services and Cigna. His appointment introduces additional operational and deal-making expertise to AMN's boardroom. AMN Healthcare Services, trading at $27.66, has had a mixed share price record, with the stock up 32.3% over the past month and up 82.9% year to date, while still down over longer 3 and 5 year periods...
NasdaqCM:EOSE
NasdaqCM:EOSEElectrical

How A Profitable Quarter And Cerberus JV At Eos Energy Enterprises (EOSE) Has Changed Its Investment Story

In May 2026, Eos Energy Enterprises reported first-quarter 2026 results showing sales of US$56.96 million and net income of US$508.88 million, reaffirmed its full-year 2026 revenue outlook of US$300 million to US$400 million, and detailed cash and share activity by several directors. Eos Energy Enterprises also announced with Cerberus Capital Management the creation of Frontier Power USA to fund and operate long-duration storage projects using Eos’s Z3 technology, while filing a broad shelf...
NYSE:WMS
NYSE:WMSBuilding

Is It Time To Revisit Advanced Drainage Systems (WMS) After The Recent Share Price Pullback

Investors may be wondering whether Advanced Drainage Systems, at around US$133 per share, still offers value or whether most of the story is already reflected in the current price. The stock is down about 1.9% over the past week and about 13.5% over the past month. It is still up 21.5% over the last year and 38.3% over three years, with a 19.8% return over five years and an 11.1% decline so far this year. Recent attention on the stock has focused on its role in water management...
NYSE:EMR
NYSE:EMRElectrical

A Look At Emerson Electric (EMR) Valuation After New AI Platforms And L&T Technology Partnership

Recent product and partnership news around Emerson Electric (EMR), centered on AI driven test automation and industrial data platforms, has put the stock back on many investors' watchlists. See our latest analysis for Emerson Electric. These AI focused launches and the new L&T Technology partnership come as the share price sits at US$136.42, with a 1-year total shareholder return of 17.25% and a 3-year total shareholder return of 81.24%. This suggests solid long term momentum, despite a 90...